Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL: 2070)

Saudi Pharmaceutical Industries and Medical Appliances Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	240	160.07	335.35	328.32	331.07	378.97
Short-Term Investments	-	115.5	45	-	128.99	-
Trading Asset Securities	-	0.46	0.42	567.67	614.56	27.83
Cash & Short-Term Investments	240	276.03	380.77	895.99	1,075	406.8
Cash Growth	1.62%	-27.51%	-57.50%	-16.62%	164.16%	52.19%
Accounts Receivable	1,298	924.09	758.9	971.8	980.52	930.95
Other Receivables	-	32.82	147.12	94.29	102.88	89.05
Receivables	1,298	956.91	906.03	1,066	1,083	1,020
Inventory	604	589.21	494.69	419.09	458.06	409.53
Prepaid Expenses	-	22.98	23.73	23.99	18.6	15.47
Other Current Assets	314	130.17	70.56	57.16	39.87	71.59
Total Current Assets	2,456	1,975	1,876	2,462	2,675	1,923
Property, Plant & Equipment	1,807	1,838	1,829	1,818	1,827	1,720
Long-Term Investments	-	58.19	46.53	63.3	80.41	890.45
Other Intangible Assets	-	59.77	50.33	69.54	81.29	97.87
Long-Term Accounts Receivable	-	57.56	-	-	-	-
Long-Term Deferred Tax Assets	-	28.6	23.48	18.93	17.5	23.72
Long-Term Deferred Charges	-	6.55	6.67	1.9	1.55	-
Other Long-Term Assets	204	-	-	-	-	-
Total Assets	4,467	4,024	3,832	4,434	4,683	4,656
Accounts Payable	536	333.49	223.01	303.65	345.99	403.78
Accrued Expenses	-	208.83	87.14	125.91	90.59	69.45
Short-Term Debt	-	2.05	197.32	170.15	270.17	357.78
Current Portion of Long-Term Debt	1,037	523.41	479.64	682.6	416.36	176.48
Current Portion of Leases	-	7.21	6.15	7.26	3.32	3.69
Current Income Taxes Payable	-	48.45	33.14	28.84	39.66	37.12
Other Current Liabilities	426	281.19	322.44	321.34	405.59	451.67
Total Current Liabilities	1,999	1,405	1,349	1,640	1,572	1,500
Long-Term Debt	524	575.28	379.83	417.12	649.07	663.86
Long-Term Leases	-	11.3	18.81	17.69	12.71	7.97
Long-Term Unearned Revenue	-	81.93	77.95	70.23	67.69	58.14
Total Liabilities	2,841	2,356	2,139	2,441	2,612	2,541
Common Stock	1,200	1,200	1,200	1,200	1,200	1,200
Retained Earnings	-31	356.68	366.29	649.68	664.49	320.96
Treasury Stock	-20	-8	-	-	-	-
Comprehensive Income & Other	323	-42.03	-26.79	-11.91	51.04	422.58
Total Common Equity	1,472	1,507	1,540	1,838	1,916	1,944
Minority Interest	154	161.38	153.6	155.64	155.43	170.59
Shareholders' Equity	1,626	1,668	1,693	1,993	2,071	2,114
Total Liabilities & Equity	4,467	4,024	3,832	4,434	4,683	4,656
Total Debt	1,561	1,119	1,082	1,295	1,352	1,210
Net Cash (Debt)	-1,321	-843.22	-700.97	-398.82	-277.01	-802.98
Net Cash Per Share	-	-7.03	-5.84	-3.32	-2.31	-6.69
Filing Date Shares Outstanding	-	120	120	120	120	120
Total Common Shares Outstanding	-	120	120	120	120	120
Working Capital	457	570.66	526.94	822.58	1,103	423.41
Book Value Per Share	-	12.56	12.83	15.31	15.96	16.20
Tangible Book Value	1,472	1,447	1,489	1,768	1,834	1,846
Tangible Book Value Per Share	-	12.06	12.41	14.74	15.29	15.38
Land	-	120.93	122.04	122.05	122.27	122.05
Buildings	-	1,006	772.75	776.76	776.96	696.27
Machinery	-	1,156	1,106	1,107	1,104	994.67
Construction In Progress	-	534	753.81	686.46	672.49	708.23

Source: S&P Capital IQ. Standard template. Financial Sources.